6/3/24 17:37 | 5/31/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | | S | -43 | 11.93 | 0 | -4 | -9 | 37 | D | | | | | | | | | | | | | | |
5/28/24 20:18 | 5/24/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | | M.d | 44 | 5.90 | 0 | 8 | 23 | 41 | D | | | | | | | | | | | | | | |
3/4/24 17:25 | 3/1/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 74 | 10.45 | 0 | 7 | | 0 | D | | | | | | | | | | | | | | |
3/4/24 17:25 | 3/1/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -262 | 12.78 | 0 | -21 | -100 | 0 | D | | | | | | | | | | | | | | |
2/20/24 16:42 | 2/16/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 7 | 99 | 13 | D | | | | | | | | | | | | | | |
2/13/24 20:56 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 9 | 73 | 21 | D | | | | | | | | | | | | | | |
2/13/24 20:46 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 4 | 8 | 59 | D | | | | | | | | | | | | | | |
2/13/24 17:25 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 21 | 12 | 201 | D | | | | | | | | | | | | | | |
2/13/24 17:21 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 7 | 270 | 9 | D | | | | | | | | | | | | | | |
2/13/24 17:16 | 2/10/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 | | 5 | D | | | | | | | | | | | | | | |
2/7/24 20:41 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.ad | 0 | 0.00 | 0 | 10 | 22 | 56 | D | | | | | | | | | | | | | | |
2/6/24 16:45 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 18 | | 15 | D | | | | | | | | | | | | | | |
2/6/24 16:33 | 2/4/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 30 | 18 | 191 | D | | | | | | | | | | | | | | |
2/6/24 16:32 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 10 | 22 | 56 | D | | | | | | | | | | | | | | |
2/6/24 16:31 | 2/3/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 8 | | 5 | D | | | | | | | | | | | | | | |
1/8/24 18:48 | 1/4/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 14 | 9.41 | 0 | 2 | 3 | 50 | D | | | | | | | | | | | | | | |
1/8/24 18:48 | 1/4/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -23 | 15.00 | 0 | -2 | -3 | 50 | D | | | | | | | | | | | | | | |
1/4/24 19:04 | 1/2/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 49 | 5.42 | 0 | 9 | | 3 | D | | | | | | | | | | | | | | |
1/4/24 19:04 | 1/2/24 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -130 | 14.45 | 0 | -9 | -74 | 3 | D | | | | | | | | | | | | | | |
12/5/23 19:12 | 12/1/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 | | 3 | D | | | | | | | | | | | | | | |
12/5/23 19:12 | 12/1/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -271 | 13.56 | 0 | -20 | -86 | 3 | D | | | | | | | | | | | | | | |
11/7/23 17:16 | 11/3/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 | | 3 | D | | | | | | | | | | | | | | |
11/7/23 17:16 | 11/3/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -300 | 15.00 | 0 | -20 | -86 | 3 | D | | | | | | | | | | | | | | |
11/3/23 16:32 | 11/1/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 | | 3 | D | | | | | | | | | | | | | | |
11/3/23 16:32 | 11/1/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -282 | 14.12 | 0 | -20 | -86 | 3 | D | | | | | | | | | | | | | | |
10/11/23 20:53 | 10/10/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 17 | 9.41 | 0 | 2 | 4 | 50 | D | | | | | | | | | | | | | | |
10/11/23 20:53 | 10/10/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -26 | 15.01 | 0 | -2 | -3 | 50 | D | | | | | | | | | | | | | | |
10/4/23 16:35 | 10/2/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 217 | 5.42 | 0 | 40 | | 3 | D | | | | | | | | | | | | | | |
10/4/23 16:35 | 10/2/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -595 | 14.88 | 0 | -40 | -93 | 3 | D | | | | | | | | | | | | | | |
10/3/23 20:26 | 10/2/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 47 | 9.41 | 0 | 5 | 11 | 50 | D | | | | | | | | | | | | | | |
10/3/23 20:26 | 10/2/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -75 | 15.03 | 0 | -5 | -9 | 50 | D | | | | | | | | | | | | | | |
9/5/23 17:05 | 9/1/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 | | 3 | D | | | | | | | | | | | | | | |
9/5/23 17:05 | 9/1/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -290 | 14.48 | 0 | -20 | -86 | 3 | D | | | | | | | | | | | | | | |
8/25/23 18:47 | 8/24/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 6 | 9.41 | 0 | 1 | 1 | 50 | D | | | | | | | | | | | | | | |
8/25/23 18:47 | 8/24/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -9 | 15.02 | 0 | -1 | -1 | 50 | D | | | | | | | | | | | | | | |
8/24/23 12:30 | 8/23/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 328 | 9.41 | 0 | 35 | 231 | 50 | D | | | | | | | | | | | | | | |
8/24/23 12:30 | 8/23/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -523 | 15.01 | 0 | -35 | -41 | 50 | D | | | | | | | | | | | | | | |
8/10/23 16:31 | 8/8/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D | | S | -21,585 | 14.39 | 0 | -1,500 | -62 | 926 | I | | | | | | | | | | | | | | |
8/10/23 11:57 | 8/8/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 177 | 4.41 | 0 | 40 | | 3 | D | | | | | | | | | | | | | | |
8/10/23 11:57 | 8/8/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -595 | 14.87 | 0 | -40 | -93 | 3 | D | | | | | | | | | | | | | | |
8/9/23 19:26 | 8/8/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 24 | 9.41 | 0 | 3 | 5 | 50 | D | | | | | | | | | | | | | | |
8/9/23 19:26 | 8/8/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -39 | 15.05 | 0 | -3 | -5 | 50 | D | | | | | | | | | | | | | | |
8/8/23 16:23 | 8/7/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 66 | 8.16 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
8/8/23 16:23 | 8/7/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -117 | 14.55 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
6/16/23 16:30 | 6/14/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D | | S | -6,340 | 12.68 | 0 | -500 | -17 | 2,426 | I | | | | | | | | | | | | | | |
5/19/23 16:30 | 5/18/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D | | S | -10,550 | 10.55 | 0 | -1,000 | -26 | 2,915 | I | | | | | | | | | | | | | | |
5/5/23 20:58 | 5/4/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -191 | 10.90 | 0 | -18 | -85 | 3 | D | | | | | | | | | | | | | | |
3/1/23 17:02 | 2/27/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 18 | | 0 | D | | | | | | | | | | | | | | |
3/1/23 17:02 | 2/27/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -232 | 10.38 | 0 | -22 | -100 | 0 | D | | | | | | | | | | | | | | |
3/1/23 16:59 | 2/27/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 60 | 51 | 178 | D | | | | | | | | | | | | | | |
3/1/23 16:57 | 2/27/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 21 | 70 | 50 | D | | | | | | | | | | | | | | |
3/1/23 16:54 | 2/27/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 35 | | 21 | D | | | | | | | | | | | | | | |
3/1/23 16:52 | 2/27/23 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 | | 2 | D | | | | | | | | | | | | | | |
12/8/22 16:41 | 12/6/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D | | S | -17,400 | 11.60 | 0 | -1,500 | -28 | 3,915 | I | | | | | | | | | | | | | | |
11/10/22 16:54 | 11/8/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -651 | 12.47 | 0 | -52 | -96 | 2 | D | | | | | | | | | | | | | | |
8/17/22 17:17 | 8/15/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D | | S | -44,040 | 14.68 | 0 | -3,000 | -36 | 5,415 | I | | | | | | | | | | | | | | |
8/10/22 20:59 | 8/8/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 19 | 112 | 36 | D | | | | | | | | | | | | | | |
8/10/22 20:59 | 8/9/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -134 | 16.92 | 0 | -8 | -18 | 36 | D | | | | | | | | | | | | | | |
8/10/22 20:55 | 8/8/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 26 | 97 | 53 | D | | | | | | | | | | | | | | |
8/10/22 20:55 | 8/9/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -444 | 16.92 | 0 | -26 | -33 | 53 | D | | | | | | | | | | | | | | |
8/10/22 20:43 | 8/8/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 30 | 26 | 145 | D | | | | | | | | | | | | | | |
8/10/22 20:43 | 8/9/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | S.d | -252 | 16.92 | 0 | -15 | -9 | 145 | D | | | | | | | | | | | | | | |
8/10/22 20:21 | 8/8/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | | M.d | 75 | 4.97 | 0 | 15 | 257 | 21 | D | | | | | | | | | | | | | | |
8/10/22 20:21 | 8/8/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D | | S.d | -258 | 17.17 | 0 | -15 | -42 | 21 | D | | | | | | | | | | | | | | |
5/18/22 18:16 | 5/16/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.d | 0 | 0.00 | 0 | 6 | | 4 | D | | | | | | | | | | | | | | |
5/18/22 18:16 | 5/17/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.d | -60 | 10.00 | 0 | -6 | -61 | 4 | D | | | | | | | | | | | | | | |
3/4/22 21:18 | 3/2/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 18 | 31 | 73 | D | | | | | | | | | | | | | | |
3/4/22 21:18 | 3/3/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -442 | 10.57 | 0 | -42 | -36 | 73 | D | | | | | | | | | | | | | | |
3/4/22 20:16 | 3/2/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 51 | 64 | 130 | D | | | | | | | | | | | | | | |
3/4/22 20:16 | 3/3/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | S.d | -878 | 10.56 | 0 | -83 | -39 | 130 | D | | | | | | | | | | | | | | |
3/4/22 20:04 | 3/2/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 10 | 68 | 25 | D | | | | | | | | | | | | | | |
3/4/22 20:04 | 3/3/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -254 | 10.57 | 0 | -24 | -49 | 25 | D | | | | | | | | | | | | | | |
3/4/22 20:03 | 3/2/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.d | 0 | 0.00 | 0 | 21 | | 4 | D | | | | | | | | | | | | | | |
3/4/22 20:03 | 3/3/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.d | -227 | 10.58 | 0 | -21 | -85 | 4 | D | | | | | | | | | | | | | | |
2/14/22 21:16 | 2/10/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 53 | 119 | 97 | D | | | | | | | | | | | | | | |
2/14/22 21:13 | 2/10/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 30 | 362 | 38 | D | | | | | | | | | | | | | | |
2/14/22 21:09 | 2/10/22 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 89 | 125 | 161 | D | | | | | | | | | | | | | | |
11/18/21 17:06 | 11/16/21 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.dm | 936 | 10.47 | 0 | 89 | | 8 | D | | | | | | | | | | | | | | |
11/18/21 17:06 | 11/16/21 | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.dm | -1,530 | 17.11 | 0 | -89 | -92 | 8 | D | | | | | | | | | | | | | | |
11/2/21 17:30 | 11/1/21 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -402 | 20.12 | 0 | -20 | -31 | 44 | D | | | | | | | | | | | | | | |
10/8/21 17:59 | 10/7/21 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -54 | 18.00 | 0 | -3 | -4 | 64 | D | | | | | | | | | | | | | | |
10/5/21 19:04 | 10/1/21 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -310 | 18.23 | 0 | -17 | -20 | 67 | D | | | | | | | | | | | | | | |